media

Markets

Market Nav

News Details

14/02/2024 18:34

ANG Lifesciences Ind - Board Meeting Outcome for Outcome Of Board Meeting 14.02.2024.

Pursuant to Regulation 30 & 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we would like to inform you that Board of Directors in its meeting held on Wednesday, 14th February, 2024 has considered and approved the Standalone & Consolidated Un-Audited Financial Results of the Company for the Quarter and Nine month ended on December 31, 2023 along with the Limited Review Report thereon issued by M/s Singh Bhupinder & Associates, Statutory Auditors of the Company.